|
||
|
Neuromed Pharmaceuticals
Download PDF Members: Neuromed is a biopharmaceutical company developing new and improved pain therapies. Lead drug candidate, OROS Hydromorphone®, in Phase 3 clinical development, is an extended release formulation of hydromorphone. In collaboration with Merck, Neuromed is also researching compounds designed to block the N-type calcium channel, a target linked to pain signal transmission. Separately, Neuromed is developing T-type calcium channel blockers aimed at treating acute and chronic pain, hypertension and epilepsy. Neuromed has offices in Philadelphia, Pennsylvania and Vancouver, British Columbia.
This page has been viewed 224 times since April 2007, the link to the organisation's website has been followed 50 times Recent Search Terms used to find this page: neuromed | neuromed technologies | Neuromed V6T 1Z4 Neuromed | . Search for more companies in Vancouver Search for more companies in BC This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Neuromed Pharmaceuticals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|